Category: Medications - Page 2

New Antidepressants with Better Side Effect Profiles: What’s Emerging in 2026

New Antidepressants with Better Side Effect Profiles: What’s Emerging in 2026

New antidepressants like Exxua, Zuranolone, and Auvelity offer faster relief and far fewer side effects than older SSRIs. Learn how they work, who they help most, and what barriers still stand in the way.

Why the First Generic Drug Filer Gets 180 Days of Market Exclusivity

Why the First Generic Drug Filer Gets 180 Days of Market Exclusivity

The first generic drug company to file a patent challenge gets 180 days of exclusive sales rights. But this rule, meant to lower drug prices, is often manipulated to block competition instead.

Anxiety Medications: Benzodiazepines and the Real Risks of Mixing Them with Other Drugs

Anxiety Medications: Benzodiazepines and the Real Risks of Mixing Them with Other Drugs

Benzodiazepines like Xanax and Valium work fast for anxiety but carry serious risks when mixed with opioids, alcohol, or other sedatives. Learn the real dangers, what to avoid, and safer alternatives.

Cough Suppressants and MAOIs: What You Need to Know About Dextromethorphan Risks

Cough Suppressants and MAOIs: What You Need to Know About Dextromethorphan Risks

Dextromethorphan in common cough medicines can cause life-threatening serotonin syndrome when taken with MAOI antidepressants. Learn the risks, safe alternatives, and what to do if you're on one of these drugs.

Recent Patent Cases and Generic Delays: 2023-2025 Examples

Recent Patent Cases and Generic Delays: 2023-2025 Examples

Between 2023 and 2025, FDA-approved generic drugs faced average delays of 3.2 years before reaching patients due to patent litigation. Learn how patent thickets, the 30-month stay, and complex generics are blocking access-and who’s paying the price.

Global Perspectives on Generics: How Countries Cut Drug Costs Without Compromising Care

Global Perspectives on Generics: How Countries Cut Drug Costs Without Compromising Care

Discover how countries around the world use generic drugs to cut healthcare costs-from China's aggressive bulk buying to the U.S.'s high-volume model-and why quality and sustainability are at risk as prices fall.

Opioids with MAOIs: Why This Combination Can Be Deadly and How to Avoid It

Opioids with MAOIs: Why This Combination Can Be Deadly and How to Avoid It

Combining opioids like tramadol or meperidine with MAOIs can cause fatal serotonin syndrome. Learn which opioids are dangerous, how long to wait after stopping an MAOI, and what pain relief is safe.

Medication-Induced Agranulocytosis: Infection Risks and Essential Monitoring Steps

Medication-Induced Agranulocytosis: Infection Risks and Essential Monitoring Steps

Medication-induced agranulocytosis is a rare but deadly condition that destroys infection-fighting white blood cells. Know the high-risk drugs, recognize early symptoms, and follow strict monitoring rules to prevent fatal infections.

The Beers Criteria: Potentially Inappropriate Medications for Seniors

The Beers Criteria: Potentially Inappropriate Medications for Seniors

The Beers Criteria is a vital guide for identifying medications that may be unsafe for seniors. Learn which drugs to avoid, why they're risky, and how to work with your doctor to find safer alternatives.

Stability and Shelf Life: Understanding Generic Drug Degradation and Safety Risks

Stability and Shelf Life: Understanding Generic Drug Degradation and Safety Risks

Understanding how generic drugs degrade over time and why shelf life matters for safety. Learn the science behind stability testing, real-world risks, and what patients can do to protect themselves.